Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. RUA Life Sciences plc
  6. News
  7. Summary
    AOR   GB0033360586

RUA LIFE SCIENCES PLC

(AOR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Rua Life Sciences plc Announces Update on Testing of the Elast-EonTM Sealed Vascular Graft Range

09/17/2021 | 02:00am EDT

RUA Life Sciences plc announced update on testing of the Elast-EonTM sealed vascular graft range. The presence of cellulose, a non-toxic, natural plant-based material, had been identified during chemical characterisation testing on samples of large bore vascular grafts. After undertaking a full analysis of the possible source, a secondary study was commissioned to test grafts manufactured under revised cleanroom protocols, which has now confirmed that no cellulose was present in leachable extracts from the new graft samples tested. Once the full chemical characterisation report has been received from the third-party test house, the Group will proceed to submit the 510k notification.


© S&P Capital IQ 2021
All news about RUA LIFE SCIENCES PLC
09/17Rua Life Sciences plc Announces Update on Testing of the Elast-EonTM Sealed Vascular Gr..
CI
08/31RUA LIFE SCIENCES : Agm q&a
PU
08/31RUA Life Sciences Shares Rise After US Orders Returned to Pre-Covid-19 Levels
DJ
08/31Rua Life Sciences plc Announces Retirement of David Richmond from the Board
CI
07/30RUA LIFE SCIENCES : Notice of General Meeting - 9th Jul 2021
PU
07/22RUA LIFE SCIENCES : Annual Report for the year to 31 March 2021
PU
07/21RUA LIFE SCIENCES : Proxy Form 2021
PU
07/12Rua Life Sciences plc Appoints David Richmond as Group Chief Executive Officer
CI
07/12Rua Life Sciences plc Announces Audited Consolidated Earnings Results for the Year Ende..
CI
06/25Rua Life Sciences Plc Provides Update on RUA Vascular
CI
More news
Financials
Sales 2022 1,95 M 2,69 M 2,69 M
Net income 2022 -2,73 M -3,76 M -3,76 M
Net cash 2022 1,60 M 2,20 M 2,20 M
P/E ratio 2022 -13,9x
Yield 2022 -
Capitalization 34,6 M 47,6 M 47,6 M
EV / Sales 2022 16,9x
EV / Sales 2023
Nbr of Employees 32
Free-Float 44,9%
Chart RUA LIFE SCIENCES PLC
Duration : Period :
RUA Life Sciences plc Technical Analysis Chart | AOR | GB0033360586 | MarketScreener
Technical analysis trends RUA LIFE SCIENCES PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 156,00 GBX
Average target price 525,00 GBX
Spread / Average Target 237%
EPS Revisions
Managers and Directors
Caroline Stretton Group Managing Director & Director
William Donald Brown Executive Chairman
John McKenna Executive Director & Director-Clinical Marketing
John Louis Ely Non-Executive Director
Geoffrey Alan Berg Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
RUA LIFE SCIENCES PLC2.63%48
THERMO FISHER SCIENTIFIC30.62%240 757
DANAHER CORPORATION39.88%223 934
INTUITIVE SURGICAL, INC.25.24%122 004
SIEMENS HEALTHINEERS AG40.64%77 031
EDWARDS LIFESCIENCES CORPORATION26.87%72 674